Covered recipient · General Payments record
MOSHE WEISS
Allopathic & Osteopathic Physicians Pediatrics Pediatric Endocrinology
General Payments · PY2018–2024
$2,723.39
- Reported across 112 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $378.33 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Azurity Pharmaceuticals, Inc. | $90.18 | 4 |
| Ascendis Pharma Inc | $83.35 | 3 |
| PFIZER INC. | $81.77 | 3 |
| Endo USA, Inc. | $36.91 | 2 |
| Neurocrine BioSciences, Inc. | $36.58 | 1 |
| TOLMAR, INC. | $27.29 | 1 |
| ABBVIE INC. | $22.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.25 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106322583 | CMS |
| Ascendis Pharma Inc | $28.15 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133843888 | CMS |
| Ascendis Pharma Inc | $18.48 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133846430 | CMS |
| Ascendis Pharma Inc | $36.72 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133847901 | CMS |
| Azurity Pharmaceuticals, Inc. | $23.54 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134014201 | CMS |
| Azurity Pharmaceuticals, Inc. | $22.46 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134014203 | CMS |
| Azurity Pharmaceuticals, Inc. | $21.22 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134014205 | CMS |
| Azurity Pharmaceuticals, Inc. | $22.96 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134014207 | CMS |
| Endo USA, Inc. | $19.55 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138589752 | CMS |
| Endo USA, Inc. | $17.36 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138589754 | CMS |
| Neurocrine Biosciences, Inc. | $36.58 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150817484 | CMS |
| PFIZER INC. | $25.87 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131767464 | CMS |
| PFIZER INC. | $26.46 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131839932 | CMS |
| PFIZER INC. | $29.44 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131122648 | CMS |
| Tolmar, Inc. | $27.29 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138712394 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.